Arrivano sul mercato nuove specialità medicinali: Eylea, Fluzelastix, Testex oltre a 9 nuovi farmaci equivalenti
Nuove specialità medicinali
EYLEA 1 siringa preriempita 0,184 ml 114,3 mg/ml aflibercept
BAYER AIC:042510040 1.102,23€ Cnn/OSP dal:24/01/2025
FLUZELASTIX 1 flacone spray nasale 23 g 137 mcg + 50 mcg/erogazione 120 erogazioni azelastina cloridrato/fluticasone propionato
GENETIC AIC:050384015 32,00€ C/RR dal:27/01/2025
TESTEX 1 flaconcino IM 4 ml 250 mg/ml testosterone undecanoato
SIT AIC:051015028 160,00€ C/RNRL dal:27/01/2025
Nuovi farmaci equivalenti
ATORVASTATINA PENSA PHARMA 30 cpr riv 80 mg atorvastatina calcio triidrato
TOWA PHARMACEUTICAL AIC:050704105 13,00€ A/RR dal:27/01/2025
ERIBULINA ADVANZ PHARMA 1 flaconcino EV 2 ml 0,44 mg/ml eribulina mesilato
ADVANZ PHARMA AIC:050248018 417,05€ H/OSP dal:01/02/2025
METFORMINA EG STADA ITALIA 30 cpr riv 850 mg metformina cloridrato
EG AIC:049629052 2,23€ A/RR dal:28/01/2025
SARKAMEX 28 cpr riv 20 mg + 5 mg + 12,5 mg olmesartan medoxomil/amlodipina besilato/idroclorotiazide
ADAMED AIC:048466015 8,72€ A/RR dal:24/01/2025
SARKAMEX 28 cpr riv 40 mg + 10 mg + 12,5 mg olmesartan medoxomil/amlodipina besilato/idroclorotiazide
ADAMED AIC:048466039 8,72€ A/RR dal:24/01/2025
SARKAMEX 28 cpr riv 40 mg + 10 mg + 25 mg olmesartan medoxomil/amlodipina besilato/idroclorotiazide
ADAMED AIC:048466054 8,72€ A/RR dal:24/01/2025
SARKAMEX 28 cpr riv 40 mg + 5 mg + 12,5 mg olmesartan medoxomil/amlodipina besilato/idroclorotiazide
ADAMED AIC:048466027 8,72€ A/RR dal:24/01/2025
SARKAMEX 28 cpr riv 40 mg + 5 mg + 25 mg olmesartan medoxomil/amlodipina besilato/idroclorotiazide
ADAMED AIC:048466041 8,72€ A/RR dal:24/01/2025
TERIFLUNOMIDE HCS 28 cpr riv 14 mg teriflunomide
HCS BV AIC:050545084 688,87€ A/RR dal:28/01/2025